Sinofn Health
Luxembourg stands at the heart of European innovation, offering an unparalleled ecosystem for Foods for Special Medical Purposes (FSMP). As a pivotal hub for pharmaceutical and nutraceutical distribution, establishing manufacturing bridges in this region ensures compliance with rigorous EFSA (European Food Safety Authority) guidelines while enabling rapid distribution across the EU Single Market. SINOFN leverages this strategic positioning to bridge Eastern manufacturing efficiency with Western regulatory precision.
The global FSMP market is transitioning from general supplementation to "Precision Nutrition." Our technology roadmap focuses on Bioavailability Optimization and Metabolic Disorder Formulations. By integrating the R&D expertise from the Chinese Academy of Sciences with European clinical standards, we are setting a new benchmark for therapeutic diets—from PKU management to geriatric cellular performance.
Medical Innovation Director
Ph.D Peking University Medical School. 15+ years of expertise in metabolic disorder formulations.
R&D Lead
CAS Postdoc. Specialist in advanced bioactive compound delivery systems.
Access to global R&D, cost-efficient production scales, and rigorous compliance tracking for international markets.
Yes, from PKU-specialized diets to cognitive health enhancers, we utilize clinical-grade manufacturing processes.